In 2024, we saw the expanded use of synthetic data and natural language processing transform drug discovery and development. In a batch of predictions published in December of 2023, one expert predicted that synthetic data was set to “take off” in drug research. In 2025, the pendulum could begin swinging back the other way, according…
The opportunities and challenges inherent in using protein biomarkers for new drug development
Difficulties diagnosing disease earlier, failure to demonstrate efficacy, questions about safety and the sheer cost of testing constantly threaten new therapeutic development. But greater understanding and more widespread use of protein biomarkers have the potential to improve that narrative. A biomarker indicates a medical state that can be measured accurately and reproducibly from outside a…